Senior insider sale
SVP, General Counsel at SAREPTA THERAPEUTICS, INC. — senior position signals high conviction
$6.38M
38.96K shares
What this filing means
BROWN RYAN EDWARD plans to sell 38.96K shares of SAREPTA THERAPEUTICS, INC. valued at approximately $6.38M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 6/25/2024ACC: 0001950047-24-005009
Officer· SVP, General Counsel
Since Feb 2021
38.96K
Shares to sell
$6.38M
Approx. market value
38.96K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months3
Exercise of Stock Options
Cash
6/25/2024
23.50KRestricted Stock Units
N/A
5/31/2020
14.91KEmployee Stock Purchase Plan
Cash
8/31/2019
546.00Total acquired38.96K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
6/25/2024 | Exercise of Stock Options Cash | 23.50K | — |
5/31/2020 | Restricted Stock Units N/A | 14.91K | — |
8/31/2019 | Employee Stock Purchase Plan Cash | 546.00 | — |
| Total | 38.96K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
38.96K
Market value
$6.38M
6/25/2024
Total
Units
38.96K
Value
$6.38M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
6/25/2024 | 38.96K | $6.38M | NASDAQ | Planned |
| Total | 38.96K | $6.38M | ||